Health
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study – Yahoo Finance
A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-…
- New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced
- Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study
- Reduced COVID-19 replication by up to 96%, study performed by Public Health England (PHE) scientists
- Mode of action complementary to COVID-19 vaccines, with …
Continue Reading
-
Business20 hours agoA key reason why many ASX fund managers underperformed last financial year
-
Business16 hours agoWhat could happen to the big 4 banks in FY26?
-
Noosa News19 hours ago2025’s Melbourne International Film Festival Is Opening with the Rose Byrne-Starring ‘If I Had Legs I’d Kick You’
-
Noosa News20 hours agoCharity gala funds 18 vital pieces of peadiatric medical equipment